Stock · NSE
LAURUSLABS
1,537.80▲ 30.40 (2.02%)Last 2 days · 15m candles11/7/2026, 00:50:04
Open: 1,507.00High: 1,545.20Low: 1,504.10Prev: 1,507.40
News mentioning LAURUSLABS
VERIFIEDET Stocks·11d★ ON YOUR LIST
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthAI summary· POSITIVE
- ·Nine BSE Midcap stocks reached new 52-week highs on Monday.
- ·Aurobindo Pharma was among the mid-cap stocks that hit 52-week highs.
- ·Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services, and Laurus Labs were notable outperformers.
VERIFIEDET Markets·11d★ ON YOUR LIST
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a monthAI summary· POSITIVE
- ·Nine BSE Midcap stocks reached new 52-week highs on Monday.
- ·Aurobindo Pharma was among the mid-cap stocks that hit 52-week highs.
- ·Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services, and Laurus Labs were noted outperformers.
VERIFIEDEconomic Times News·14d★ ON YOUR LIST
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveAI summary· POSITIVE
- ·Laurus Labs' stock has increased by 30% following strong FY26 results.
- ·The company is investing ₹3,000 crore to expand capacities, especially for CDMO services.
- ·Analysts have raised earnings forecasts and maintained a 'BUY' rating for the stock.
VERIFIEDET Markets·17d★ ON YOUR LIST
GE Vernova among 9 midcap stocks hit 52-week highs, rally up to 25% in a monthAI summary· POSITIVE
- ·Nine BSE MidCap stocks, including GE Vernova, Bharat Forge, and Laurus Labs, reached new 52-week highs.
- ·These stocks saw gains of up to 25% within the last month.
- ·The rally occurred despite a significant decline in the Sensex.
VERIFIEDET Markets·18d★ ON YOUR LIST
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM FinancialAI summary· NEUTRAL
- ·JM Financial expects Laurus Labs and Biocon to be added to the MSCI India Standard Index.
- ·Ather Energy and SAIL are considered medium-probability candidates for inclusion.
- ·SBI Card has a high probability of being excluded from the index.
VERIFIEDET Stocks·18d★ ON YOUR LIST
Laurus Labs, Biocon, Ather Energy, Lenskart among probable MSCI India Standard Index inclusion candidates, says JM FinancialAI summary· NEUTRAL
- ·JM Financial expects Laurus Labs and Biocon to be added to the MSCI India Standard Index.
- ·Ather Energy and SAIL are considered medium-probability candidates for inclusion.
- ·SBI Card has a high probability of being excluded from the index.
VERIFIEDMint Markets·35d★ ON YOUR LIST
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends 3 stocks to buy today amid RBI policy - 5 June 2026VERIFIEDET Stocks·39d★ ON YOUR LIST
Market Trading Guide: NMDC among two stock recommendations for TuesdayAI summary· NEGATIVE
- ·Indian benchmark indices extended losses for a fourth straight session.
- ·FII selling and geopolitical concerns hurt market sentiment.
- ·Analysts recommend NMDC and Laurus Labs based on technical indicators.
VERIFIEDMint Markets·50d★ ON YOUR LIST
Stocks to buy today: Choice Broking, Anand Rathi, PL Capital pick 8 shares for todayAI summary· NEUTRAL
- ·Choice Broking, Anand Rathi, and PL Capital have selected 8 shares for trading on 21 May 2026.
- ·Triveni Turbine, Laurus Labs, and Syrma SGS Technology are among the recommended stocks.
- ·These selections are based on strong technical indicators and perceived buying opportunities.
VERIFIEDET Stocks·52d★ ON YOUR LIST
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?AI summary· POSITIVE
- ·Laurus Labs added over Rs 40,150 crore to investors' wealth in one year.
- ·The company's stock experienced a 120% rally.
- ·Business improvements, better margins, and strong earnings drove the market cap surge.
VERIFIEDET Stocks·58d★ ON YOUR LIST
Vodafone Idea and 4 other midcap stocks hit 52-week highs, rally up to 40% in a monthAI summary· POSITIVE
- ·Five BSE 150 Midcap stocks, including Vodafone Idea, SAIL, MCX, Laurus Labs, and Ajanta Pharma, reached new 52-week highs.
- ·These stocks have shown significant monthly gains, with some rallying up to 40%.
- ·The surge in these midcap stocks indicates strong investor sentiment and sustained buying interest.